21600 ⎘
Preparations containing radioactive substances for use in therapy or testing characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules Solutions, i.e. homogeneous liquid formulation
[177LU] LUTETIUM-PSMA I&T COMPOSITION AND DOSIMETRY, KIT, METHOD OF MAKING, AND METHOD OF USING THEREOF
#2METHODS FOR LARGE SCALE SYNTHESIS OF RADIONUCLIDE COMPLEXES
#3RADIOISOTOPE DELIVERY SYSTEM WITH MULTIPLE DETECTORS TO DETECT GAMMA AND BETA EMISSIONS
#4PREPARATION METHOD FOR LIQUID COMPOSITION COMPRISING COMPOUND I AND USE IN MYOCARDIAL PERFUSION PET IMAGING
#5METHOD AND SYSTEM FOR THE CONCENTRATION OF RADIUM AND ACTINIUM FROM DILUTE SOLUTIONS
#6TERAGNOSTIC METHOD FOR CANCER PATIENTS
#7STABILIZED COMPOSITIONS OF RADIONUCLIDES AND USES THEREOF
#8Radiopharmaceutical and Methods
#9STABILIZED RADIOPHARMACEUTICAL COMPOSITION
#10METHOD OF TREATMENT OF NEUROENDOCRINE TUMORS
#11RADIOPHARMACEUTICALS, METHODS FOR THE PRODUCTION THEREOF, AND USES IN TREATMENT, DIAGNOSIS AND IMAGING DISEASES
#123D PRINTING OF SOLID-STATE PHANTOMS
#13PREPARATION OF A PH-ADJUSTED ASCORBIC ACID SOLUTION
#14METHOD FOR MANUFACTURING AND INCREASING THE YIELD OF A MEDICAL STRONTIUM-82/RUBIDIUM-82 GENERATOR
#15[161Tb]-BASED RADIOPEPTIDES
#16DIAGNOSTIC METHODS OF PROSTATE CANCER
#17RADIOISOTOPE DELIVERY SYSTEM WITH MULTIPLE DETECTORS TO DETECT GAMMA AND BETA EMISSIONS
#18STABILIZED COMPOSITIONS OF RADIONUCLIDES AND USES THEREOF
#19RADIOPHARMACEUTICAL AND METHODS
#20RADIOPHARMACEUTICAL COMPOSITIONS OF COPPER FOR TARGETED MOLECULAR IMAGING
#21METHODS FOR RADIOLABELLING PSMA BINDING LIGANDS AND THEIR KITS
#22METHOD FOR PRODUCING 225AC SOLUTION
#23ASTATINE SOLUTION AND METHOD FOR PRODUCING SAME
#24RADIOPHARMACEUTICAL AND METHODS
#25Stabilized compositions of radionuclides and uses thereof
#26[161 tb]-based radiopeptides
#27Method and device for direct production of radio-isotope based cancer treatment pharmaceuticals
#28[161Tb]-BASED RADIOPEPTIDES
#29METHODS FOR RADIOLABELING PSMA BINDING LIGANDS AND THEIR KITS
#30Stabilized compositions of radionuclides and uses thereof
#31Urokinase Plasminogen Activator Receptor-Targeted Radiopharmaceutical
#32RADIOPHARMACEUTICAL AND METHODS
#33METHODS FOR RADIOLABELLING GRPR ANTAGONISTS AND THEIR KITS
#34ONE STEP 64Cu-BaBaSar-RGD2 PRODUCTION METHOD
#35METHOD OF TREATMENT OF NEUROENDOCRINE TUMORS
#36Radiopharmaceutical and methods
#37Methods for Synthesis of Radionuclide Complex
#38Pharmaceutical Composition Comprising a Radiolabeled GRPR Antagonist and a Surfactant
#39Radiopharmaceutical and methods
#40Stable, concentrated radionuclide complex solutions
#41PURIFICATION METHOD AND COMPOSITIONS
#42SOLUTION COMPRISING FLUORESCENT DYE AS FIDUCIAL MARKER
#43Composition Containing a Somatostatin Analogue for Radiopharmaceutical Use
#44Apparatus of producing nuclide using fluid target
#45SODIUM SACCHARIN HAVING CONJUGATED LIGAND, DERIVATIVES THEREOF AND PROCESS FOR THE PREPARATION THEREOF
#46Astatine solution and method for producing same
#47RADIOPHARMACEUTICAL SYNTHESIS METHODS
#48Reinforced macrocyclic ligands, complexes thereof, and uses of same
#49Methods for Synthesis of Radionuclide Complex
#50Systems and techniques for generating, infusing, and controlling radioisotope delivery
#51Radioisotope delivery system with multiple detectors to detect gamma and beta emissions
#52Stable, concentrated radionuclide complex solutions
#53Stable, concentrated radionuclide complex solutions
#54Shielding assembly for a radioisotope delivery system having multiple radiation detectors
#55METHOD AND APPARATUS FOR PREPARING A RADIOLABELED PHARMACEUTICAL
#56One step 64Cu-BaBaSar-RGD2 production method
#57MODIFIED DEXTRAN CONJUGATES COMPRISING A LYSINE-UREA-GLUTAMATE PHARMACOPHORE
#58FORMULATIONS FOR 2-HETEROARYL SUBSTITUTED BENZOFURANS
#59DOTMP KIT FORMULATIONS FOR RADIOISOTOPES
#60Radiopharmaceutical solutions with advantageous properties
#61Radiopharmaceutical conjugate of a metabolite and an EPR agent, for targeting tumour cells
#62TRANSPORTABLE LONG-LIVED HYPERPOLARIZED SAMPLES
#63PURIFICATION METHOD AND COMPOSITIONS
#64Formulation, apparatus and method for stabilizing radiopharmaceuticals
#65Formulation, apparatus and method for stabilizing radiopharmaceuticals
#66Method for production of F-18 labeled amyloid beta ligands
#67Radiopharmaceutical synthesis methods
#68Bioerodible sustained release drug delivery systems
#69Apparatus for fractionation and infusion of radiopharmaceutical products
#70Cancer therapy
#71Formulation, apparatus and method for stabilizing radiopharmaceuticals
#72Unsealed, Non-Colloidal Radiopharmaceutical Compositions and Methods for Treatment of Abnormal Tissue
#73METHODS FOR REDUCING TOXICITIES ASSOCIATED WITH MEDICAL PROCEDURES EMPLOYING RADIOGRAPHIC CONTRAST AGENTS
#74STABILIZATION OF RADIOPHARMACEUTICALS
#75Stabilized compositions and methods for radiolabeling pharmaceuticals with alpha-particle emitters
#76Gentisic acid for stabilising 123-I radiopharmaceuticals
#77Presentation of an antiviral pharmaceutical composition
#78Radioactive arsenic-containing compounds and their uses in the treatment of tumors
#79Composition for medical use having improved water-solubility of peptide and metal-labeling efficiency and preparation for medical use comprising metal-labeled peptide
#80Stabilization of radiopharmaceutical compositions using hydrophilic 6-hydroxy chromans
#81Compositions, methods, apparatuses, and systems for singlet oxygen delivery
#82Method for obtaining a 2- F fluor-2-deoxy-D-glucose F-FDG-solution
#83Bioerodible sustained release drug delivery systems
#84Molecular imaging of the cochlea
#85Stabilized compositions of radionuclides and uses thereof
#86Stabilized compositions of radionuclides and uses thereof